Filter by patients with: All

What is AIDA (ATRA and Idarubicin)?

Category: Prescription Drugs

false

See also: All-transretinoic Acid Idarubicin

This regimen is used to induce remission in newly diagnosed acute promyelocytic leukemia and includes ATRA (all-trans-retinoic acid) given by mouth daily until a complete remission or for a maximum of 90 days and Idarubicin (Idamycin) given IV on days 2,4,6,8. One cycle lasts a maximum of 90 days.

See patients taking AIDA (ATRA and Idarubicin)

No patients have reported taking AIDA (ATRA and Idarubicin).
Last updated:
There are no evaluations for AIDA (ATRA and Idarubicin).